Literature DB >> 682426

Hemodialysis bone disease: correlation between clinical, histologic, and other findings.

F Alvarez-Ude, T G Feest, M K Ward, A M Pierides, H A Ellis, M Peart, W Simpson, D Weightman, D N Kerr.   

Abstract

This paper explores in patients with dialysis osteodystrophy the relationship between clinical features and histological, radiological, and biochemical findings. Eighty-five patients treated by hemodialysis for more than 6 months were studied. The following conclusions were drawn: 1) Bone pain in patients on regular hemodialysis is usually a symptom of developing osteomalacia but not of hyperparathyroidism or osteoporosis. 2) Many patients with histological osteomalacia and radiological features of osteomalacia, such as fractures or Looser zones, have no symptoms. 3)In dialysis patients, biochemical and radiological abnormalities are not a reliable means of predicting the presence of osteomalacia, but a raised serum alkaline phosphatase is a good indicator of the presence of osteitis fibrosa. For early detection of osteomalacia, bone biopsy in necessary. 4)A number of our dialysis patients develop an unusual form of osteomalacia characterized by absent or minimal histological osteitis fibrosa, a normal serum alkaline phosphatase, and a high incidence of myopathy and fractures.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 682426     DOI: 10.1038/ki.1978.90

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Impaired muscle strength is associated with fractures in hemodialysis patients.

Authors:  S A Jamal; R E Leiter; V Jassal; C J Hamilton; D C Bauer
Journal:  Osteoporos Int       Date:  2006-06-24       Impact factor: 4.507

2.  Dialysis myopathy. Report of 13 cases.

Authors:  J Bautista; E Gil-Necija; J Castilla; I Chinchon; E Rafel
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 3.  Recent advances and controversies in childhood renal osteodystrophy.

Authors:  O Mehls; I B Salusky
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

4.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11

5.  Renal bone disease among patients with ESRD.

Authors:  Seyed Seifollah Beladi Mousavi; Hossein Saghafi
Journal:  Nephrourol Mon       Date:  2013-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.